A dual-inhibition study on vascular smooth muscle cells with meclofenamic acid and β-irradiation for the prevention of restenosis.

[1]  A. Lumsden,et al.  Evolving Modalities for Femoropopliteal Interventions , 2009, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[2]  H. Gurm,et al.  Routine stent implantation vs. percutaneous transluminal angioplasty in femoropopliteal artery disease: a meta-analysis of randomized controlled trials. , 2008, European heart journal.

[3]  S. Yazdani,et al.  Development of an in vitro system to assess stent-induced smooth muscle cell proliferation: a feasibility study. , 2009, Journal of vascular and interventional radiology : JVIR.

[4]  Deepak L. Bhatt,et al.  The effect of drug-eluting stents on intermediate angiographic and clinical outcomes in diabetic patients: insights from randomized clinical trials. , 2008, American heart journal.

[5]  K. Robinson,et al.  Drug-eluting stents: present and future. , 2008, Cardiovascular & hematological agents in medicinal chemistry.

[6]  Ho-Young Song,et al.  Liquid (188)Re-filled balloon dilation for the treatment of refractory benign airway strictures: preliminary experience. , 2008, Journal of vascular and interventional radiology : JVIR.

[7]  L. Monge,et al.  Endothelin-1 potentiation of coronary artery contraction after ischemia-reperfusion. , 2008, Vascular pharmacology.

[8]  Michael J. Lee,et al.  Does percutaneous transluminal angioplasty improve quality of life? , 2008, Journal of vascular and interventional radiology : JVIR.

[9]  B. Marczewska,et al.  Dose Perturbation Caused by Stents: Experiments with a Model 90Sr/90Y Source , 2007, CardioVascular and Interventional Radiology.

[10]  M. Schwake,et al.  Molecular expression and pharmacological identification of a role for Kv7 channels in murine vascular reactivity , 2007, British journal of pharmacology.

[11]  W. Gerthoffer.  Mechanisms of vascular smooth muscle cell migration. , 2007, Circulation research.

[12]  M. Haberal,et al.  Evaluation of Neointimal Hyperplasia on Tranilast-Coated Synthetic Vascular Grafts: An Experimental Study , 2007, Journal of investigative surgery : the official journal of the Academy of Surgical Research.

[13]  Jean-Paul Beregi,et al.  Drug-Eluting and Bare Nitinol Stents for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery: Long-Term Results from the SIROCCO Trial , 2006, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[14]  D. C. Brewster,et al.  Intermediate results of percutaneous endovascular therapy of femoropopliteal occlusive disease: a contemporary series. , 2006, Journal of vascular surgery.

[15]  A. Hannekum,et al.  Edge restenosis: impact of low dose irradiation on cell proliferation and ICAM-1 expression , 2006, BMC cardiovascular disorders.

[16]  G. Tepe.  Drug-eluting stents for infrainguinal occlusive disease: progress and challenges. , 2006, Seminars in vascular surgery.

[17]  C. Kirisits,et al.  Randomized blinded clinical trial of intracoronary brachytherapy with 90Sr/Y beta-radiation for the prevention of restenosis after stent implantation in native coronary arteries in diabetic patients. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[18]  P. Fitzgerald,et al.  Predictors of edge stenosis following sirolimus-eluting stent deployment (a quantitative intravascular ultrasound analysis from the SIRIUS trial). , 2005, The American journal of cardiology.

[19]  Shelly R. Peyton,et al.  Extracellular matrix rigidity governs smooth muscle cell motility in a biphasic fashion , 2005, Journal of cellular physiology.

[20]  Samin K. Sharma,et al.  Two-year clinical follow-up of 90Sr/90 Y β-radiation versus placebo control for the treatment of in-stent restenosis , 2005 .

[21]  Wolfgang Schöber,et al.  The Effects of Paclitaxel on the Three Phases of Restenosis: Smooth Muscle Cell Proliferation, Migration, and Matrix Formation: An In Vitro Study , 2004, Investigative radiology.

[22]  Qingbo Xu,et al.  Mechanical stress‐activated PKCδ regulates smooth muscle cell migration , 2003 .

[23]  P. Teirstein,et al.  Intracoronary Radiation Therapy Improves the Clinical and Angiographic Outcomes of Diffuse In-Stent Restenotic Lesions: Results of the Washington Radiation for In-Stent Restenosis Trial for Long Lesions (Long WRIST) Studies , 2003, Circulation.

[24]  B. Meier,et al.  25 years of coronary angioplasty: almost a fairy tale , 2003, The Lancet.

[25]  J. Dennis,et al.  Origin and Differentiation of Human and Murine Stroma , 2002, Stem cells.

[26]  C. Claussen,et al.  Meclofenamic Acid for Inhibition of Human Vascular Smooth Muscle Cell Proliferation and Migration: An In Vitro Study , 2002, CardioVascular and Interventional Radiology.

[27]  T. Saruta,et al.  Tranilast inhibits interleukin-1beta-induced monocyte chemoattractant protein-1 expression in rat mesangial cells. , 2001, European journal of pharmacology.

[28]  P. Tsao,et al.  Low Blood Flow After Angioplasty Augments Mechanisms of Restenosis: Inward Vessel Remodeling, Cell Migration, and Activity of Genes Regulating Migration , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[29]  S. Schwartz,et al.  Monoclonality of smooth muscle cells in human atherosclerosis. , 1997, The American journal of pathology.

[30]  K. Ichikawa,et al.  Tranilast suppresses the vascular intimal hyperplasia after balloon injury in rabbits fed on a high-cholesterol diet. , 1996, European journal of pharmacology.

[31]  V. Fuster,et al.  Management of restenosis after coronary intervention. , 1996, American heart journal.

[32]  K. Miyazawa,et al.  Tranilast suppresses intimal hyperplasia in the balloon injury model and cuff treatment model in rabbits. , 1996, Japanese journal of pharmacology.

[33]  M G Stabin,et al.  MIRDOSE: personal computer software for internal dose assessment in nuclear medicine. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[34]  S. Epstein,et al.  The basis of molecular strategies for treating coronary restenosis after angioplasty. , 1994, Journal of the American College of Cardiology.

[35]  K. Malik,et al.  Cytokine stimulation of prostaglandin production inhibits the proliferation of serum-stimulated mesangial cells. , 1994, Kidney international.

[36]  M. Reidy,et al.  Factors controlling the development of arterial lesions after injury. , 1992, Circulation.

[37]  M. Reidy,et al.  Regulation of Smooth Muscle Cell Growth in Injured Artery , 1989, Journal of cardiovascular pharmacology.